about
Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) studyImpact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after studyHigh-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC studyCommon carotid arterial interadventitial distance (diameter) as an indicator of the damaging effects of age and atherosclerosis, a cross-sectional study of the Atherosclerosis Risk in Community Cohort Limited Access Data (ARICLAD), 1987-89.Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) studyGenome-wide association analysis identifies six new loci associated with forced vital capacityGenome-wide association and large-scale follow up identifies 16 new loci influencing lung function.Bilateral common carotid artery ultrasound for prediction of incident strokes using intima-media thickness and external diameter: an observational study.Common carotid artery wall thickness and external diameter as predictors of prevalent and incident cardiac events in a large population study.MR Imaging Measures of Intracranial Atherosclerosis in a Population-based Study.Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study.Risk of Cardiovascular Disease from Cumulative Cigarette Use and the Impact of Smoking IntensityEffects of periodontal therapy on rate of preterm delivery: a randomized controlled trialVital exhaustion and retinal microvascular changes in cardiovascular disease: atherosclerosis risk in communities study.Comparison of spatially matched airways reveals thinner airway walls in COPD. The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study and the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS)Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study.Correlates of prone infant sleeping position by period of birthDesign of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)The effect of alcohol treatment on social costs of alcohol dependence: results from the COMBINE study.Orthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study.Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.Baseline trajectories of heavy drinking and their effects on postrandomization drinking in the COMBINE Study: empirically derived predictors of drinking outcomes during treatment.Do retinopathy signs in non-diabetic individuals predict the subsequent risk of diabetes?Indoor air pollutants and health in the United Arab EmiratesThree-year incidence and cumulative prevalence of retinopathy: the atherosclerosis risk in communities study.Age-related macular degeneration and long-term risk of stroke subtypes.Racial differences in association of elevated interleukin-18 levels with type 2 diabetes: the Atherosclerosis Risk in Communities studyAssociation of Single Nucleotide Polymorphisms in the ST3GAL4 Gene with VWF Antigen and Factor VIII Activity.Estimated plasma stearoyl co-A desaturase-1 activity and risk of incident diabetes: the Atherosclerosis Risk in Communities (ARIC) studyImproving the efficiency of estimation in the additive hazards model for stratified case-cohort design with multiple diseases.Recalibration of blood analytes over 25 years in the atherosclerosis risk in communities study: impact of recalibration on chronic kidney disease prevalence and incidence.A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistanceLung function decline over 25 years of follow-up among black and white adults in the ARIC study cohortRepeatability of Central and Peripheral Pulse Wave Velocity Measures: The Atherosclerosis Risk in Communities (ARIC) StudyA controlled statistical study to assess measurement variability as a function of test object position and configuration for automated surveillance in a multicenter longitudinal COPD study (SPIROMICS)Longitudinal Patterns of Change in Systolic Blood Pressure and Incidence of Cardiovascular Disease: The Atherosclerosis Risk in Communities StudyRace and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study.Chronic inflammation role in the obesity-diabetes association: a case-cohort study.Characteristics of first-time alcohol treatment seekers: the COMBINE Study.Vital exhaustion as a risk factor for adverse cardiac events (from the Atherosclerosis Risk In Communities [ARIC] study).
P50
Q23911282-6DF32243-0E3B-4D1A-9EDC-41E9095605EBQ24603076-6E3683C9-39B0-487B-809D-66BA7B7CA6FDQ24618394-D9BE1CFB-73EB-4902-9C10-3B3B09613A99Q25257628-2E1C2CA4-107A-4221-8343-FE7D7F1BCA1DQ28210322-6F73D694-3D7C-4B13-A230-D9BE3510A2B8Q30408891-57681C82-00D5-419C-B0FA-0312810074FFQ30427183-A4D0214E-6561-40E7-97CC-3AAC624775D8Q30453314-E85C238F-7ABE-4307-84A3-86974012E6A8Q30499427-7B94B8CC-F722-4FA9-99D0-09B65B19152DQ31064440-EA53935B-1E03-4904-844B-C81D1E030F10Q33653182-B56AA24D-7799-42C9-AFFF-56EF2F316C93Q33828249-3AC60C67-76FF-49E6-9894-C5BA7C407B3AQ34051804-69437555-4BBE-42EA-B5C7-1304394FDD70Q34330035-E8D29403-9230-42D3-9CD0-817D5EFCD75EQ34345197-E03C673C-5559-4377-83EA-1E39DA3BCCB8Q34711313-6F75B2DB-E04A-4232-B738-856EC260514AQ34795908-4C5164FE-D490-49C3-A0BA-431B08AE3217Q35041299-0173FD0D-CE26-4BAD-BDC3-8DE384F4E873Q35087485-8473DE14-14FA-4E96-96A8-7CF7125A8B02Q35137813-0E900D76-9F49-49ED-8063-4557961B5598Q35576129-F5A59DA3-BA26-467B-83FB-35C9DC16A79DQ35696834-A1ECCB7E-5430-430B-9EBA-EF8AC21D5007Q35761602-7B059EBC-C23E-4EA5-BBF1-C1860E3D740EQ35941808-C591F0DA-80C1-4119-A6B8-DFF1CBAE1BD5Q35946063-7EA2AE6C-6B87-4824-99FD-A641C8377221Q35992264-35990D06-1EB9-459B-84AE-940B7A8A0FC9Q36047267-6C819D3D-7566-49FF-98FF-50D3D20AD0C8Q36120096-B9C35384-FA48-46F2-9F77-695ADA0F4939Q36456941-EF84DEFB-2084-4A40-91D4-F0763AF5E406Q36470771-EA8DBF0F-BFAB-48BD-8DBE-92DF02E1EE7CQ36661937-8C09B34D-1F1F-4FBE-BE5E-57CFF5D7C902Q36731268-2153C3FA-D50C-4E63-959C-45DE1C7C2823Q36739637-E4087040-DCDB-40F2-ADC5-D06844F85D6BQ36851473-150A6679-6066-4AE5-83DD-D874DC7F53B4Q36853369-3C9F52F4-2D23-49A1-AADE-DA509434FA50Q36896629-0DC797E4-2A04-41E7-994A-C8BBA29D060EQ36957797-DA04FE7D-DD65-4885-B7FF-E7C81F0E75AEQ36972552-B27462BF-53F1-4CF6-BFB0-505D9CB63DA5Q36973917-43FB714C-A6D5-4732-8043-9D0E629BCFB8Q37055594-BD882C47-3EB6-4CAC-B8D9-AB4A1A41BCCB
P50
description
researcher ORCID ID = 0000-0002-4313-9235
@en
wetenschapper
@nl
name
David Couper
@ast
David Couper
@en
David Couper
@es
David Couper
@nl
type
label
David Couper
@ast
David Couper
@en
David Couper
@es
David Couper
@nl
prefLabel
David Couper
@ast
David Couper
@en
David Couper
@es
David Couper
@nl
P106
P21
P31
P496
0000-0002-4313-9235